Marta Sánchez Pérez

Institutions of which they are part

Diabetes and Metabolism

Vall Hebron Institut de Recerca

Marta Sánchez Pérez

Institutions of which they are part

Diabetes and Metabolism

Vall Hebron Institut de Recerca

Related news

Dra. Andreea Ciudin, Marta Comas i Juan José Cortés

A new oral drug for obesity shows positive results in an international study

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Equip del grup de Diabetis i Metabolisme del VHIR

Fundaluce supports research into a new therapeutic strategy for retinitis pigmentosa

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.